Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
Enanta Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -96.42M | -104.93M | -116.05M | -115.33M | -131.74M | -138.24M | -133.82M | -132.06M | -124.69M | -120.63M | -121.75M | -120.01M | -112.33M | -100.78M | -79M | -83.74M | -73.98M | -57.94M |
Depreciation & Amortization | 4.61M | 2.58M | 2.34M | 2.53M | 2.58M | 2.5M | 2.37M | 2.36M | 2.42M | 2.7M | 2.97M | 3.12M | 3.23M | 3.24M | 3.33M | 3.44M | 3.53M | 3.61M |
Stock-Based Compensation | 23.49M | 24.36M | 26.8M | 25.79M | 27.37M | 29.18M | 28.22M | 28.33M | 28.94M | 28.05M | 26.97M | 25.49M | 23.36M | 22.17M | 20.99M | 20.38M | 19.66M | 19.36M |
Other Working Capital | 14.89M | 14.64M | 6.57M | 2.71M | 319K | 4.45M | -299K | -4.88M | -5.69M | -18.51M | 8.16M | 290.74M | 583.79M | 992.65M | 978.03M | 696.2M | 404.56M | 2.86M |
Other Non-Cash Items | -1.23M | -1.22M | 746K | -7.48M | -6.14M | -6.9M | -8.03M | -891K | -1.26M | -169K | -304K | -345K | -2.68M | -2.95M | -3.5M | -3.66M | -1.93M | -3.18M |
Deferred Income Tax | n/a | n/a | 274K | 353K | -1.09M | -1.09M | -1.37M | -1.45M | n/a | n/a | 546K | 891K | 1.45M | 1.98M | 1.86M | 16.49M | 12.79M | 10.38M |
Change in Working Capital | 14.08M | 8.63M | 7.13M | 4.17M | 248K | 20.61M | 8.02M | 5.17M | 36K | -17.11M | 6.79M | 578K | -3.21M | 7.96M | -13.69M | -17.35M | 513K | 7.6M |
Operating Cash Flow | -55.46M | -70.58M | -78.76M | -89.97M | -107.32M | -92.5M | -103.15M | -97.09M | -94.56M | -107.15M | -84.78M | -90.27M | -90.17M | -68.38M | -70M | -64.44M | -39.42M | -20.16M |
Capital Expenditures | -26.78M | -25.91M | -17.95M | -10.37M | -5.97M | -6.69M | -9.06M | -9.13M | -7.23M | -4.92M | -2.13M | -721K | -869K | -925K | -750K | -1.05M | -921K | -1.15M |
Cash Acquisitions | n/a | n/a | 12.33M | 12.33M | 155.93M | 106.78M | 57.72M | 28.06M | -132.01M | -82.86M | -46.14M | -16.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -150.16M | -160.44M | -307.28M | -413.4M | -494.9M | -452.86M | -373.39M | -276.01M | -137.44M | -175.92M | -171.45M | -162.11M | -260.39M | -265.58M | -307.35M | -378.92M | -338.25M | -325.77M |
Sales Maturities Of Investments | 254.2M | 326.6M | 383.46M | 474.76M | 412.47M | 359.29M | 328.87M | 247.95M | 269.45M | 223.8M | 228.47M | 262.18M | 300.69M | 366.44M | 345.09M | 346.77M | 376.47M | 366.5M |
Other Investing Acitivies | n/a | n/a | -12.33M | -12.33M | -12.33M | 36.82M | 85.87M | 115.54M | 132.01M | 47.88M | 57.02M | 100.07M | 40.29M | 100.86M | 37.74M | -32.14M | 38.22M | 40.73M |
Investing Cash Flow | 77.26M | 140.25M | 58.23M | 51M | -88.41M | -100.26M | -53.58M | -37.18M | 124.78M | 42.97M | 54.9M | 99.35M | 39.42M | 99.94M | 36.99M | -33.19M | 37.3M | 39.59M |
Debt Repayment | -12.21M | -12.21M | -14.43M | -7.17M | -7.17M | -7.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -183K | -183K | -183K | -183K | n/a | -1K | -1K | -1K | -1K | n/a | -534K | -534K | -534K | -534K | -1.5M | -1.5M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -13.72M | -13.3M | -13.34M | -13.35M | 193.2M | 197.64M | 198.13M | 201.08M | 5.32M | 10.7M | 20.03M | 18.05M | 14.61M | 12.41M | 3.08M | 2.37M | 4.91M | 8.12M |
Financial Cash Flow | -25.73M | -25.26M | -27.63M | -20.43M | 186.09M | 190.47M | 198.13M | 201.08M | 5.32M | 10.7M | 20.03M | 18.05M | 14.61M | 12.41M | 3.08M | 2.37M | 4.91M | 8.12M |
Net Cash Flow | -3.94M | 44.42M | -48.16M | -59.4M | -9.64M | -2.29M | 41.39M | 66.81M | 35.55M | -53.48M | -9.85M | 27.13M | -36.14M | 43.97M | -29.93M | -95.25M | 2.79M | 27.54M |
Free Cash Flow | -82.24M | -96.48M | -96.71M | -100.33M | -113.29M | -99.19M | -112.21M | -106.21M | -101.79M | -112.07M | -86.91M | -90.99M | -91.04M | -69.3M | -70.75M | -65.48M | -40.34M | -21.31M |